NextCure Operating Expenses 2011-2026 | NXTC

Annual Operating Expenses NextCure

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
59.7 M	67.6 M	75.9 M	70.8 M	63.6 M	43.8 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
75.9 M	43.8 M	63.6 M

Quarterly Operating Expenses NextCure

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
8.94 M	27.3 M	11.6 M	-	12.5 M	16.5 M	18.3 M	-	15.6 M	19.2 M	17.1 M	-	19.2 M	18.1 M	20.8 M	-	18.5 M	18 M	17.2 M	-	17.4 M	15.8 M	14.2 M	-	11.3 M	10.4 M	8.17 M	-	5.82 M	5.3 M	5.01 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
27.3 M	5.01 M	14.7 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	948 M	$ 20.29	-1.98 %	$ 2.56 B	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	20.7 M	$ 0.8	-5.29 %	$ 4.36 M	China
Axsome Therapeutics AXSM	99.1 M	$ 166.62	0.14 %	$ 8.29 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
AbCellera Biologics ABCL	292 M	$ 3.76	-1.7 %	$ 1.12 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Burford Capital Limited BUR	106 M	$ 8.45	-3.26 %	$ 1.38 B	Britain
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	49.3 M	$ 25.77	-4.06 %	$ 690 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Codexis CDXS	31.5 M	$ 0.97	-5.15 %	$ 71.2 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	46 M	$ 3.15	-5.69 %	$ 1.13 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	543 M	$ 28.45	-2.57 %	$ 1.65 B	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Завод ДИОД DIOD	249 M	-	-	-	Russia
Фармсинтез LIFE	201 M	-	-	-	Russia
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Cellectis S.A. CLLS	109 M	$ 3.65	-3.95 %	$ 116 M	France
Alector ALEC	177 M	$ 2.1	-5.2 %	$ 216 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	103 M	$ 4.16	-0.12 %	$ 295 M	USA
Teligent, Inc. TLGT	548 K	-	-13.85 %	$ 16.1 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Viela Bio, Inc. VIE	163 M	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Catalyst Pharmaceuticals CPRX	206 M	$ 23.99	0.46 %	$ 2.93 B	USA
Amarin Corporation plc AMRN	171 M	$ 13.89	-0.32 %	$ 5.76 B	Irlanda
AbbVie ABBV	12.8 B	$ 231.88	-1.0 %	$ 410 B	USA
Blueprint Medicines Corporation BPMC	428 M	-	-	$ 8.14 B	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
AIM ImmunoTech AIM	14.4 M	$ 0.71	-8.96 %	$ 34.1 M	USA